Press Releases

Varian Announces Global Clinical Consortium to Develop Evidence-based Protocols for Adaptive Radiotherapy

Bringing together a global community of clinicians and scientists from leading cancer clinics to develop best practices for adaptive radiotherapy based on clinical evidence, Varian (NYSE: VAR)...

Varian Reports Results for Second Quarter of Fiscal Year 2019

Second Quarter 2019 Summary – Oncology gross orders grew 15% in dollars, or 18% in constant currency – Total company revenues grew 7% in dollars, or 10% in constant currency, to $779 million...

First Varian Halcyon Treatments in Kenya Begin at Nairobi West Hospital

Varian (NYSE: VAR) today announced that The Nairobi West Hospital in Nairobi, Kenya is the first clinic in the country and in West, Central, and East Africa to begin treating cancer patients using...

Varian to Demonstrate Advanced Cancer Care Solutions at ESTRO 38

Varian (NYSE: VAR) today announced it will be showcasing its new single-room proton therapy system, ProBeam® 360°, and the Bravos™ afterloader system for High Dose Rate (HDR) brachytherapy...

Varian Installs Cyclotron for ProBeam Proton Therapy System at Hefei Ion Medical Center in China

Varian (NYSE: VAR) today announced the installation of the cyclotron for the Varian ProBeam® proton therapy system at Hefei Ion Medical Center (HIMC) in China. The cyclotron is a core piece of...

Varian Opens Office in South Africa to Support Regional Growth

At a grand opening ceremony held March 8th, the Varian office in Hertford Office Park, Midrand, Johannesburg, South Africa was officially inaugurated. Prior to the opening of the permanent...

Varian Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment

At the American Association for Cancer Research (AACR) Annual Meeting in Atlanta, GA, Varian (NYSE: VAR), in partnership with the University of Maryland School of Medicine's Department of...

Beacon Hospital Treats First Patient in Malaysia on Varian Halcyon System

Varian (NYSE: VAR) today announced a 62-year-old male with thyroid cancer was the first patient in Malaysia to be treated on the Halcyon™ system at Beacon Hospital in Selangor. Halcyon...

Korea University Medical Center Completes First Varian Halcyon System Treatment in Korea

Varian (NYSE: VAR) today announced a 55-year-old male with liver cancer at the Korea University Medical Center Anam Hospital, was the first patient in Korea to receive treatment on the Halcyon™...

Varian Wins "Best After-Sales Service Award for Radiotherapy Products" in China Two Years In A Row

Varian (NYSE: VAR) today announced it again received the "Best After-Sales Service Award for Radiotherapy Products" in the 2018 Chinese Medical Devices Industry Data and After-Sales Service...